Regorafenib in patients with advanced Ewing sarcoma: results of a non-comparative, randomised, double-blind, placebo-controlled, multicentre Phase II study.

Autor:	Duffaud, Florence1 (AUTHOR) florence.duffaud@ap-hm.fr, Blay, Jean-Yves2 (AUTHOR), Le Cesne, Axel3 (AUTHOR), Chevreau, Christine4 (AUTHOR), Boudou-Rouquette, Pascaline5 (AUTHOR), Kalbacher, Elsa6 (AUTHOR), Penel, Nicolas7 (AUTHOR), Perrin, Christophe8 (AUTHOR), Laurence, Valérie9 (AUTHOR), Bompas, Emmanuelle10 (AUTHOR), Saada-Bouzid, Esma11 (AUTHOR), Delcambre, Corinne12 (AUTHOR), Bertucci, François13 (AUTHOR), Cancel, Mathilde14 (AUTHOR), Schiffler, Camille15 (AUTHOR), Monard, Laure16 (AUTHOR), Bouvier, Corinne17 (AUTHOR), Vidal, Vincent18 (AUTHOR), Gaspar, Nathalie19 (AUTHOR), Chabaud, Sylvie15 (AUTHOR)
Zdroj:	British Journal of Cancer. Dec2023, Vol. 129 Issue 12, p1940-1948. 9p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu Full text from SpringerLink